• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    OKYO Pharma Limited - Ordinary Shares (NQ:OKYO)

    1.640 -0.020 (-1.20%)
    Streaming Delayed Price Updated: 1:36 PM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 73,902
    Open 1.600
    Bid (Size) 1.590 (100)
    Ask (Size) 1.620 (6,500)
    Prev. Close 1.660
    Today's Range 1.590 - 1.664
    52wk Range 1.140 - 3.349
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire

    Performance

    YTD
    -26.5%
    -26.5%
    1 Month
    +4.5%
    +4.5%
    3 Month
    -23.7%
    -23.7%
    6 Month
    -32.5%
    -32.5%
    1 Year
    +40.2%
    +40.2%

    More News

    Read More
    News headline image
    OKYO Pharma Announces Director Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
    From OKYO Pharma LTD
    Via GlobeNewswire
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    Traders are paying attention to the gapping stocks in Friday's session. ↗
    Via Chartmill
    News headline image
    OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    Which stocks are moving after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    OKYO Pharma Announces Public Offering of Ordinary Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Successful Type C Meeting with the FDA
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    Friday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma to Ring the Opening Bell at Nasdaq
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma Announces Chairman and Founder Acquires Shares
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma to Present at OIS XV in San Diego
    From OKYO Pharma LTD
    Via GlobeNewswire
    News headline image
    OKYO Pharma to Present at BIO-Europe 2025 in Vienna
    From OKYO Pharma LTD
    Via GlobeNewswire

    Frequently Asked Questions

    Is OKYO Pharma Limited - Ordinary Shares publicly traded?
    Yes, OKYO Pharma Limited - Ordinary Shares is publicly traded.
    What exchange does OKYO Pharma Limited - Ordinary Shares trade on?
    OKYO Pharma Limited - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for OKYO Pharma Limited - Ordinary Shares?
    The ticker symbol for OKYO Pharma Limited - Ordinary Shares is OKYO on the Nasdaq Stock Market
    What is the current price of OKYO Pharma Limited - Ordinary Shares?
    The current price of OKYO Pharma Limited - Ordinary Shares is 1.640
    When was OKYO Pharma Limited - Ordinary Shares last traded?
    The last trade of OKYO Pharma Limited - Ordinary Shares was at 04/20/26 01:36 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.